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Abstract
Objectives: A prospective study to evaluate the changes in A-Scan 
axial parameters of phakic normal eyes before and after instillation 
of 1% topical Tropicamide and 2% Homatropine eye drops.
Methods:  Anterior  chamber  depth,  lens  thickness,  vitreous 
chamber length, and ocular axial length were measured in 76 eyes 
before and after cycloplegia induced by 1% topical Tropicamide, 
and in 28 eyes with 2% Homatropine eye drops.
Results:  Anterior  chamber  depth  demonstrated  increase  from 
baseline readings with Tropicamide and Homatropine eye drops, 
while lens thickness showed decrease from the baseline readings 
with both eye drops. Effect of both the eye drops on over all axial 
length and vitreous chamber length is statistically seen, but is 
clinically negligible and not significant.
Conclusion: Cycloplegia induced by 1% Tropicamide eye drops 
and  2%  Homatropine  eye  drops  has  a  significant  measurable 
influence on anterior chamber depth and lens thickness, while 
vitreous chamber length and overall axial length demonstrated 
negligible  statistical  difference  on  A-Scan  parameters  of  the 
normal phakic eyes.
Keywords: Anterior chamber depth (ACD), Axial length (AXL), 
Vitreous chamber length (VCL), Lens thickness (LT), Cycloplegia, 
A-Scan, Tropicamide, Homatropine.
Introduction
One  percent  Tropicamide  eye  drop  and  2%  Homatropine 
eye drops are commonly used eye drops in day to day ophthalmic 
practice.  Tropicamide  is  an  acetylcholine  receptor  blocker 
drug,  which  has  short  acting  cycloplegic  and  mydriatic  effect. 
Homatropine belongs to Anticholinergic group which has more 
potent cycloplegic effect then Tropicamide. Both the drugs having 
known  effect  on  the  axial  parameters  of  the  eye  like  anterior 
chamber  depth  (ACD),lens  thickness  (LT),  vitreous  chamber 
length (VCL), and axial length (AXL) of the eye.
ACD measurement provides valuable information in different 
fields of ophthalmology. In cataract surgery and phakic intraocular 
lens [IOL] implantation, precise ACD measurements are required 
to determine IOL power and position and to prevent endothelial 
cell damage.1 ACD measurement assessment can also provide an 
indicator of glaucoma, with the anterior chamber being shallower 
in patients at risk.
Different devices capable of measuring the ACD are based 
on variety of techniques and can classified accordingly. The most 
commonly and widely used method is the A-Scan
ultrasonic method and its measurements of ACD and other 
axial  parameters  represent  the  “Gold  Standard”  for  biometric 
dimension.1 The accuracy of a measuring instrument is an essential 
factor when selecting a device for clinical purpose. The purpose 
of this study was to demonstrate the effect on axial parameters 
of the eye, after instillation of 1% Tropicamide eye drop and 2% 
Homatropine eye drop.
Methods
This  study  was  conducted  in  the  out  patient  department  of 
Ophthalmology.  The  A-Scan  used  to  measure  the  anterior 
chamber  depth,  lens  thickness,  vitreous  chamber  length,  and 
axial length, was the Alcon ultrasonic scan using a frequency of 
10 MHz.
Measurement  of  the  effects  of  topically  instilled  1% 
Tropicamide (76 eyes) and 2% Homatropine eye drop (28 eyes) 
was done in patients who sought treatment for their eye problems. 
All the patients included in this study were informed of the nature 
of the study and had given verbal consent to participate. Complete 
ocular examination was done in each case, before hand, to rule out 
any other ocular disease affecting the procedure. The exclusion 
criteria from the study was, cases of glaucoma, shallow anterior 
chamber, deep anterior chamber, past history of ocular surgery, 
patients with high refractive error (more than 2 Diopter), use of 
contact lens, patients below 10 years and above 45 yrs, pregnancy, 
diabetic patients, and lack of co-operation.
The base line reading before the instillation of 1% Tropicamide 
and  2%  Homatropine  was  done  which  included  assessment  of 
anterior chamber depth, lens thickness, vitreous chamber length, 
and overall axial length of the eye. The anesthesia required for 
A-Scan was gained by instilling one drop of 0.5% Proparacaine 
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hydrochloride in each eye.
One drop of tropicamide and Homatropine was instilled twice 
at the interval of 15 minutes in respective group patients. The 
reading 45 minutes after instillation of the 1% Tropicamide and 
60 minutes after the instillation of Homatropine were done using 
the same parameters. All the measurements were made in straight 
ahead position using ultrasonic transducer.
Results
A  total  of  76  eyes  with  Tropicamide  and  28  eyes  with 
Homatropine  were  examined.  The  mean  age  of  the  subjects 
was  24.7  years  in  the  Tropicamide  group  while  12.1  years  in 
Homatropine  group.  The  limit  of  agreement  was  used  as  the 
indicator  of  the  similar  trend  seen  in  the  patients  on  various 
A-scan parameters after using tropicamide or homatropine eye 
drops in the study group.
In our study the mean average increase in ACD in Tropicamide 
group recorded was 0.25 mm from the initial ACD of 3.16 mm 
(SD: 0.45) (Fig. 1). Limit of agreement was seen in 84.21% of 
patients (Fig. 2). While in Homatropine group the mean average 
increase in ACD recorded was 0.29 mm from the initial ACD of 
3.09 mm (SD: 0.36 mm) (Fig 3). Limit of agreement was seen in 
89.28% of the patients (Fig. 2). The increase in the ACD is due to 
axial flattening of the lens because of cycloplegia.
Figure  1:  Effect  of  1%  Tropicamide  on  A-Scan  parameters  of 
phakic eyes
Figure 2: Limit of agreement
Figure 3: Effect of 2% Homatropine on A-Scan parameters of 
phakic eyes 
Number  of  patients  in  percentile  shows  increase  in  ACD, 
decrease in LT, increase in AXL and decrease in VCL in both 
groups.
The average decrease in the LT in Tropicamide group recorded 
was 0.21 mm, from the initial LT of 3.92 mm (SD: 0.34) (Fig. 
1). Limit of agreement was seen in 72.37% of the patients (Fig. 
2). While the average decrease in the LT in Homatropine group 
recorded was 0.24 mm, from the initial LT of 3.87 mm (SD: 
0.29 mm) (Fig. 3). The limit of agreement was seen in 75% of the 
patients (Fig. 2). The decrease in the LT is due to axial flattening of 
the lens because of cycloplegia.
There was decrease of 0.02 mm in the VCL in Tropicamide 
group from the initial of 15.94 mm [SD: 0.74] (Fig. 1). The limit 
of agreement of decrease in VCL was seen in only 42.11%, while 
40.79% showed increase in VCL (Fig. 2). There was 0.05 mm 
increase in VCL in Homatropine group from the initial VCL of 
15.45 mm (SD: 0.48) (Fig. 3). Limit of agreement of increase in 
VCL was seen only in 46.43% while 39.28% showed decrease in 
VCL (Fig. 2).
Over all AXL in Tropicamide group increased by 0.03 mm 
from the initial average AXL of 23.02 mm (SD: 0.89) (Fig. 1).The 
limit of agreement was seen in only 47.37%, while similar number 
of patients showed decrease in AXL (Fig. 2). In Homatropine 
group the overall AXL increased by 0.05 mm from the average 
baseline readings of 22.41 mm (SD: 0.56) (Fig. 3). The limit of 
agreement was seen in 60.71% of the patients while 39.28% of the 
patients in Homatropine group showed decrease in overall AXL 
(Fig. 2)
Discussion
In this study we measured the axial parameters by A – Scan 
Ultrasound which is widely available and most commonly used 
device  in  general  ophthalmic  units  and  represent  the  “Gold 
Standard” for biometric dimension.1
Instillation of 1% Tropicamide eye drops and 2% Homatropine 
eye  drops  has  a  deepening  effect  on  anterior  chamber  depth 
resulting in increase in anterior chamber depth.2-4
Our results of increase in ACD after using Tropicamide and 
Homatropine eye drops corresponds with the results of Mehrotra 
Effect of 1% 
Tropicamide on A-scan 
parameters of phakic 
eyes 
[N-76] 
Baseline Figures 
 
AXL  23.02 +/- 0.89 
ACD  03.16 +/- 0.45 
LT  03.92 +/- 0.34 
VCL  15.94 +/- 0.75 
45 minutes after instillation 
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VCL  15.92 +/- 0.72 
Mean difference 
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Effect of 2% 
Homatropine on A- 
scan parameters of 
Phakic eyes 
[N-28] 
Baseline 
AXL  22.41 +/- 0.56 
ACD  03.09 +/- 0.36 
LT  0.3.87 +/- 0.29 
VCL  15.45 +/- 0.48 
60 minutes post instillation 
AXL  22.46 +/- 0.56 
ACD  03.38 +/- 0.27 
LT  03.63 +/- 0.16 
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LT  -  0.24 
VCL  + 0.05 
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AS,2 Mutti DO,5 Marchini et al 6 and Sheng H 4 who all reported 
increase  in  ACD  after  mydriasis  either  with  Tropicamide  or 
Homatropine eye drops.
Cycloplegia  induces  decrease  in  LT  due  to  axial  flattening 
of the lens. We also report decrease in LT after mydriasis with 
Tropicamide and Homatropine eye drops. Our results of decrease 
in LT after mydriasis correspond with the results shown by Mutti 
DO 5 and Marchini.6
The overall AXL increased statistically in both groups, but 
with  lower  level  of  limits  of  agreements.  (Tropicamide  group 
47.3%, Homatropine group 60.71%)
The VCL increased in Homatropine group [limit of agreement 
46.43%] while it is decreased in Tropicamide group by 0.02 mm 
(limit of agreement 42.11%).
Hence  in  our  study  the  effect  of  mydriasis  induced  by 
Tropicamide and Homatropine on ACD and LT is statistically 
conclusive and comparable to other studies with high levels of limit 
agreement. The effect on overall AXL and VCL is variable and not 
conclusive due to low levels of limit of agreements.
Conclusion
In the present study 1% Tropicamide and 2% Homatropine eye 
drops have shown a measurable and conclusive deepening effect on 
the ACD by 0.25 mm in Tropicamide group and by 0.29 mm in 
Homatropine group from the initial baseline readings, attributed 
to axial flattening of the lens because of cycloplegia. Similarly 
it has got statistically significant effect on LT which decreases 
on an average by 0.21mm in Tropicamide group and 0.24 mm 
in  Homatropine  group.  Cycloplegia  induced  by  Tropicamide 
and  Homatropine  eye  drops  had  no  significant  effect  on  the 
VCL and the overall AXL of the eye. The reliability of overall 
AXL and VCL after mydriasis was not conclusive, as the results 
were variable and limits of agreements were low. As expected, 
Homatropine has got stronger cycloplegic effect on ACD and LT 
as compared to Tropicamide, which is reflected statistically on 
both the parameters.
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